Rafael Vazquez-Villanueva
Barcelona, CT 08908, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Comprehensive Clinical Characterization and Long-Term Follow-Up of the Institut Català d'Oncologia Breast Cancer Observational Cohort Study.
Journal: Cancers
Published: January 25, 2025
AZD8701, an Antisense Oligonucleotide Targeting FOXP3 mRNA, as Monotherapy and in Combination with Durvalumab: A Phase I Trial in Patients with Advanced Solid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 12, 2024
Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor-Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 15, 2023
An Open-label Phase I Study of GDC-0927 in Postmenopausal Women with Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 09, 2023
Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2- advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial.
Journal: Breast (Edinburgh, Scotland)
Published: July 21, 2022
Genomic characterization and tumor evolution in paired samples of metaplastic breast carcinoma.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: October 28, 2021
Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2- Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 01, 2021
Cancer, onco-haematological treatment and cardiovascular toxicity
Journal: Hipertension y riesgo vascular
Published: August 05, 2020
Health-related quality of life in premenopausal women with hormone-receptor-positive, HER2-negative advanced breast cancer treated with ribociclib plus endocrine therapy: results from a phase III randomized clinical trial (MONALEESA-7).
Journal: Therapeutic advances in medical oncology
Published: May 22, 2020
Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer.
Journal: The New England journal of medicine
Published: June 06, 2019
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial.
Journal: The Lancet. Oncology
Published: February 16, 2018
Showing 1-12 of 12
Last Updated: 09/26/2026